March 8, 2024
A large global report has found ongoing poor mental well-being worldwide, with no sign of improvement since prior to the COVID-19 pandemic. Published online on March […]
March 8, 2024
Sign up for E-mail Updates Transforming how we monitor the safety of FDA-regulated products Monitoring the safety of its regulated products is a major part of the […]
March 8, 2024
COPENHAGEN (Reuters) – Novo Nordisk’s CEO on Friday said compounded semaglutide in the United States is a serious health issue. Demand for Novo’s wildly popular weight-loss […]
March 8, 2024
(Reuters) -Novo Nordisk’s CEO on Friday said the company was working with authorities in several countries to tackle counterfeit versions of its popular diabetes drug Ozempic, […]
March 8, 2024
Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost […]
March 8, 2024
In a new study, patients with carotid artery plaque in which microplastics and nanoplastics were detected had a higher risk for death or major cardiovascular events […]
March 8, 2024
The US Food and Drug Administration has approved nivolumab (Opdivo, Bristol-Myers Squibb) in combination with cisplatin and gemcitabine for first-line treatment of adults with unresectable or […]
March 8, 2024
SEOUL (Reuters) -South Korea plans quick measures to improve pay and working conditions for young doctors, the government said on Friday, addressing a key demand by […]
March 8, 2024
The US Food and Drug Administration has granted accelerated approval to the Bruton’s kinase inhibitor zanubrutinib (Brukinsa, BeiGene USA) with obinutuzumab (Gazyva, Roche) for relapsed or […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626
Next page